Fund Holdings — Foresite Capital Management IV, LLC

Total Portfolio Value:
$111.07M
Total Bought:
$41.60M
Total Sold:
$7.70M
Net Transaction:
+$33.90M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Pharvaris N.V.
COM
4,397,8814,410,581+12,700$84.31M$69.25M62.35%-$15.06M
Maze Therapeutics, Inc.(MAZE)02,111,919+2,111,919$0$23.25M20.93%+$23.25M
Lyell Immunopharma, Inc.(LYEL)8,325,00016,007,999+7,682,999$5.33M$8.61M7.75%+$3.28M
Kura Oncology, Inc.(KURA)1,726,8821,111,882-615,000$15.04M$7.34M6.61%-$7.70M
Relay Therapeutics, Inc.(RLAY)1,000,0001,000,0000$4.12M$2.62M2.36%-$1.50M
Page 1 of 1
Foresite Capital Management IV, LLC — 13F Holdings — Q1 2025 | TickerTrail